Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age

BACKGROUND: The International Maternal, Pediatric, and Adolescent Clinical Trials P1060 trial demonstrated superior outcomes for HIV-infected children less than 3 years old initiating antiretroviral therapy (ART) with lopinavir/ritonavir compared to nevirapine, but lopinavir/ritonavir is four-fold c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :AIDS
Главные авторы: Ciaranello, Andrea L., Doherty, Kathleen, Penazzato, Martina, Lindsey, Jane C., Harrison, Linda, Kelly, Kathleen, Walensky, Rochelle P., Essajee, Shaffiq, Losina, Elena, Muhe, Lulu, Wools-Kaloustian, Kara, Ayaya, Samuel, Weinstein, Milton C., Palumbo, Paul, Freedberg, Kenneth A.
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2015
Предметы:
Epidemiology and Social
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536981/
https://ncbi.nlm.nih.gov/pubmed/25870982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000672
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы